Patents by Inventor Yanhong Li

Yanhong Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10886928
    Abstract: A fast phase frequency includes two fast pulsed-latches, a NAND gate, and an adjustable delay circuit, where the fast pulsed-latches include a pulse generating circuit, a reset circuit, and an output latch circuit. The pulse generating circuit is configured to generate a power supply pulse signal when a rising edge of the clock signal arrives, the power supply pulse signal causing the input of the output latch circuit to be a low level. The output latch circuit is configured to maintain its current output state when the clock signal or the reset signal is invalid, and the reset circuit is configured to set the input of the output latch circuit to be a high level. By using fast pulsed-latches with clock and reset control, the fast phase frequency detector shortens the reset loop delay and increases the maximum operating frequency of the phase frequency detector.
    Type: Grant
    Filed: February 25, 2020
    Date of Patent: January 5, 2021
    Assignee: MONTAGE TECHNOLOGY CO., LTD.
    Inventors: Pengzhan Zhang, Zhongyuan Chang, Yanhong Li
  • Patent number: 10826504
    Abstract: A time-to-digital converter and a phase difference detection method are disclosed. The time-to-digital converter includes a detection unit and a digital control circuit. The detection unit comprising: a phase detection circuit, a first and a second clock signal are respectively coupled to an identical input terminal of the phase detection circuit and a reference signal is coupled to another input terminal of the phase detection circuit; the phase detection circuit is configured to output a pulse width corresponding to a phase difference between the first or the second clock signal and the reference signal; a filter circuit, coupled to an output terminal of the phase detection circuit; a ring oscillator circuit, coupled to an output terminal of the filter circuit and configured to output an oscillation clock signal corresponding to the pulse width. The digital control circuit is configured to provide the reference signal and receive the oscillation clock signal.
    Type: Grant
    Filed: March 3, 2020
    Date of Patent: November 3, 2020
    Assignee: MONTAGE TECHNOLOGY CO., LTD.
    Inventors: Pengzhan Zhang, Yong Wang, Yanhong Li, Yaomin Wu, Zhongyuan Chang
  • Publication number: 20200304128
    Abstract: A time-to-digital converter and a phase difference detection method are disclosed. The time-to-digital converter includes a detection unit and a digital control circuit. The detection unit comprising: a phase detection circuit, a first and a second clock signal are respectively coupled to an identical input terminal of the phase detection circuit and a reference signal is coupled to another input terminal of the phase detection circuit; the phase detection circuit is configured to output a pulse width corresponding to a phase difference between the first or the second clock signal and the reference signal; a filter circuit, coupled to an output terminal of the phase detection circuit; a ring oscillator circuit, coupled to an output terminal of the filter circuit and configured to output an oscillation clock signal corresponding to the pulse width. The digital control circuit is configured to provide the reference signal and receive the oscillation clock signal.
    Type: Application
    Filed: March 3, 2020
    Publication date: September 24, 2020
    Applicant: MONTAGE TECHNOLOGY CO., LTD.
    Inventors: Pengzhan ZHANG, Yong WANG, Yanhong LI, Yaomin WU, Zhongyuan CHANG
  • Publication number: 20200295766
    Abstract: Disclosed a fast phase frequency detector, comprising: two fast pulsed-latches, a NAND gate and an adjustable delay circuit. The fast pulsed-latches comprises: a pulse generating circuit, a reset circuit, and an output latch circuit; the pulse generating circuit is configured to generate a power supply pulse signal when a rising edge of the clock signal arrives, the power supply pulse signal causing the input of the output latch circuit to be a low level; the output latch circuit is configured to maintain its current output state when the clock signal or the reset signal is invalid; the reset circuit is configured to set the input of the output latch circuit to be a high level. By using fast pulsed-latches with clock and reset control, the fast phase frequency detector of the present application shortens the reset loop delay and increases the maximum operating frequency of the phase frequency detector.
    Type: Application
    Filed: February 25, 2020
    Publication date: September 17, 2020
    Applicant: MONTAGE TECHNOLOGY CO., LTD.
    Inventors: Pengzhan ZHANG, Zhongyuan CHANG, Yanhong LI
  • Patent number: 10766916
    Abstract: Methods and compositions using E-selectin antagonists are provided for the treatment and prevention of diseases and disorders treatable by inhibiting binding of E-selectin to an E-selectin ligand. Described herein are E-selectin antagonists including, for example, glycomimetic compounds, antibodies, aptamers and peptides that are useful in methods for treatment of cancers, and treatment and prevention of metastasis, inhibiting infiltration of the cancer cells into bone marrow, reducing or inhibiting adhesion of the cancer cells to endothelial cells including cells in bone marrow, and inhibiting thrombus formation.
    Type: Grant
    Filed: November 20, 2019
    Date of Patent: September 8, 2020
    Assignee: GLYCOMIMETICS, INC.
    Inventors: John L. Magnani, Arun K. Sarkar, Myung-Gi Baek, Frank E. Anderson, III, Yanhong Li
  • Publication number: 20200190130
    Abstract: New 2-deoxy-2,3-dehydro-sialic acids and 2,7-anhydro-sialic acids, which are useful as sialidase inhibitors, and enzymatic methods for preparing them are disclosed. The methods include forming a reaction mixture comprising a glycoside acceptor, a sialic acid donor, and a sialyltransferase; maintaining the reaction mixture under conditions sufficient to form a sialoside; and contacting the sialoside with a Streptococcus pneumoniae sialidase to form the sialic acid product. Methods for the inhibition and sialidases and the treatment of cancer and infectious diseases are also disclosed.
    Type: Application
    Filed: April 27, 2018
    Publication date: June 18, 2020
    Inventors: Xi CHEN, An XIAO, Wanqing LI, Xixuan LI, Yanhong LI, Teri SLACK
  • Publication number: 20200157134
    Abstract: Methods and compositions using E-selectin antagonists are provided for the treatment and prevention of diseases and disorders treatable by inhibiting binding of E-selectin to an E-selectin ligand. Described herein are E-selectin antagonists including, for example, glycomimetic compounds, antibodies, aptamers and peptides that are useful in methods for treatment of cancers, and treatment and prevention of metastasis, inhibiting infiltration of the cancer cells into bone marrow, reducing or inhibiting adhesion of the cancer cells to endothelial cells including cells in bone marrow, and inhibiting thrombus formation.
    Type: Application
    Filed: November 20, 2019
    Publication date: May 21, 2020
    Applicant: GlycoMimetics, Inc.
    Inventors: John L. MAGNANI, Arun K. SARKAR, Myung-Gi BAEK, Frank E. ANDERSON, III, Yanhong LI
  • Patent number: 10526361
    Abstract: Methods and compositions using E-selectin antagonists are provided for the treatment and prevention of diseases and disorders treatable by inhibiting binding of E-selectin to an E-selectin ligand. Described herein are E-selectin antagonists including, for example, glycomimetic compounds, antibodies, aptamers and peptides that are useful in methods for treatment of cancers, and treatment and prevention of metastasis, inhibiting infiltration of the cancer cells into bone marrow, reducing or inhibiting adhesion of the cancer cells to endothelial cells including cells in bone marrow, and inhibiting thrombus formation.
    Type: Grant
    Filed: September 19, 2017
    Date of Patent: January 7, 2020
    Assignee: GlycoMimetics, Inc.
    Inventors: John L. Magnani, Arun K. Sarkar, Myung-Gi Baek, Frank E. Anderson, III, Yanhong Li
  • Patent number: 10160986
    Abstract: The present invention provides a one-pot multi-enzyme method for preparing UDP-sugars from simple sugar starting materials. The invention also provides a one-pot multi-enzyme method for preparing oligosaccharides from simple sugar starting materials.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: December 25, 2018
    Assignee: The Regents of the University of California
    Inventors: Xi Chen, Hai Yu, Yanhong Li, Yi Chen, Jingyao Qu, Musleh M. Muthana, Kam Lau, Lars Bode
  • Publication number: 20180066006
    Abstract: Methods and compositions using E-selectin antagonists are provided for the treatment and prevention of diseases and disorders treatable by inhibiting binding of E-selectin to an E-selectin ligand. Described herein are E-selectin antagonists including, for example, glycomimetic compounds, antibodies, aptamers and peptides that are useful in methods for treatment of cancers, and treatment and prevention of metastasis, inhibiting infiltration of the cancer cells into bone marrow, reducing or inhibiting adhesion of the cancer cells to endothelial cells including cells in bone marrow, and inhibiting thrombus formation.
    Type: Application
    Filed: September 19, 2017
    Publication date: March 8, 2018
    Applicant: GlycoMimetics, Inc.
    Inventors: John L. MAGNANI, Arun K. SARKAR, Myung-Gi BAEK, Frank E. ANDERSON, III, Yanhong LI
  • Patent number: 9796745
    Abstract: Methods and compositions using E-selectin antagonists are provided for the treatment and prevention of diseases and disorders treatable by inhibiting binding of E-selectin to an E-selectin ligand. Described herein are E-selection antagonists including, for example, glycomimetic compounds, antibodies, aptamers and peptides that are useful in methods for treatment of cancers, and treatment and prevention of metastasis, inhibiting infiltration of the cancer cells into bone marrow, reducing or inhibiting adhesion of the cancer cells to endothelial cells including cells in bone marrow, and inhibiting thrombus formation.
    Type: Grant
    Filed: June 26, 2015
    Date of Patent: October 24, 2017
    Assignee: GlycoMimetics, Inc.
    Inventors: John L. Magnani, Arun K. Sarkar, Myung-Gi Baek, Frank E. Anderson, III, Yanhong Li
  • Publication number: 20170204444
    Abstract: The present invention provides a one-pot multi-enzyme method for preparing UDP-sugars from simple sugar starting materials. The invention also provides a one-pot multi-enzyme method for preparing oligosaccharides from simple sugar starting materials.
    Type: Application
    Filed: February 5, 2016
    Publication date: July 20, 2017
    Applicant: The Regents of the University of California
    Inventors: Xi Chen, Hai Yu, Yanhong Li, Yi Chen, Jingyao Qu, Musleh M. Muthana, Kam Lau, Lars Bode
  • Publication number: 20170016040
    Abstract: The present invention provides a one-pot multi-enzyme method for preparing UDP-sugars from simple sugar starting materials. The invention also provides a one-pot multi-enzyme method for preparing oligosaccharides from simple sugar starting materials.
    Type: Application
    Filed: February 5, 2016
    Publication date: January 19, 2017
    Applicant: The Regents of the University of California
    Inventors: Xi Chen, Hai Yu, Yanhong Li, Yi Chen, Jingyao Qu, Musleh M. Muthana, Kam Lau, Lars Bode
  • Publication number: 20160145290
    Abstract: Methods and compositions using E-selectin antagonists are provided for the treatment and prevention of diseases and disorders treatable by inhibiting binding of E-selectin to an E-selectin ligand. Described herein are E-selection antagonists including, for example, glycomimetic compounds, antibodies, aptamers and peptides that are useful in methods for treatment of cancers, and treatment and prevention of metastasis, inhibiting infiltration of the cancer cells into bone marrow, reducing or inhibiting adhesion of the cancer cells to endothelial cells including cells in bone marrow, and inhibiting thrombus formation.
    Type: Application
    Filed: June 26, 2015
    Publication date: May 26, 2016
    Inventors: John L. MAGNANI, Arun K. SARKAR, Myung-Gi BAEK, Frank E. ANDERSON, III, Yanhong LI
  • Publication number: 20160002355
    Abstract: The invention provides anti-idiotypic HCMV antibodies as well as methods of using the same.
    Type: Application
    Filed: September 21, 2015
    Publication date: January 7, 2016
    Inventors: Jo-Anne Hongo, Yanhong Li, Luna Liu, John Lowe, Mauricio Maia, Rajesh Vij, Terence Wong, Keyang Xu
  • Patent number: 9229835
    Abstract: An online application system and a method for implementing an online application system are disclosed. A method for implementing the online application system includes a) receiving a user search request from a user browser; b) searching for a match according to the search request and obtaining an online application that matches with the search request to form a search result page; and c) presenting the online application before the user browser in a form as a canvas page which is embedded in the search result page and is directly accessible from the search result page. The present disclosure also provides an online application system. The technical solutions disclosed herein allow a user to directly search out an online application via a search engine without a need to click multi-level linkages, thereby providing a quick and convenient search process which enhances the users' experiences with networks.
    Type: Grant
    Filed: November 20, 2014
    Date of Patent: January 5, 2016
    Assignee: Baidu Online Network Technology (Beijing) Co., Ltd.
    Inventors: Yanhong Li, Jianting Zhu, Jinrong Wang, Jun Zhou
  • Patent number: 9229834
    Abstract: An online application system and a method for implementing an online application system are disclosed. A method for implementing the online application system includes a) receiving a user search request from a user browser; b) searching for a match according to the search request and obtaining an online application that matches with the search request to form a search result page; and c) presenting the online application before the user browser in a form as a canvas page which is embedded in the search result page and is directly accessible from the search result page. The present disclosure also provides an online application system. The technical solutions disclosed herein allow a user to directly search out an online application via a search engine without a need to click multi-level linkages, thereby providing a quick and convenient search process which enhances the users' experiences with networks.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: January 5, 2016
    Assignee: Baidu Online Network Technology (Beijing) Co., Ltd.
    Inventors: Yanhong Li, Jianting Zhu, Jinrong Wang, Jun Zhou
  • Patent number: 9139659
    Abstract: The invention provides anti-idiotypic HCMV antibodies as well as methods of using the same.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: September 22, 2015
    Assignee: GENENTECH, INC.
    Inventors: Jo-Anne Hongo, Yanhong Li, Luna Liu, John Lowe, Mauricio Maia, Rajesh Vij, Terence Wong, Keyang Xu
  • Patent number: 9109002
    Abstract: Methods and compositions using E-selectin antagonists are provided for the treatment and prevention of diseases and disorders treatable by inhibiting binding of E-selectin to an E-selectin ligand. Described herein are E-selectin antagonists including, for example, glycomimetic compounds, antibodies, aptamers and peptides that are useful in methods for treatment of cancers, and treatment and prevention of metastasis, inhibiting infiltration of the cancer cells into bone marrow, reducing or inhibiting adhesion of the cancer cells to endothelial cells including cells in bone marrow, and inhibiting thrombus formation.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: August 18, 2015
    Assignee: GlycoMimetics, Inc.
    Inventors: John L. Magnani, Arun K. Sarkar, Myung-Gi Baek, Frank E. Anderson, III, Yanhong Li
  • Publication number: 20150110808
    Abstract: Methods and compositions using E-selectin antagonists are provided for the treatment and prevention of diseases and disorders treatable by inhibiting binding of E-selectin to an E-selectin ligand. Described herein are E-selectin antagonists including, for example, glycomimetic compounds, antibodies, aptamers and peptides that are useful in methods for treatment of cancers, and treatment and prevention of metastasis, inhibiting infiltration of the cancer cells into bone marrow, reducing or inhibiting adhesion of the cancer cells to endothelial cells including cells in bone marrow, and inhibiting thrombus formation.
    Type: Application
    Filed: December 21, 2012
    Publication date: April 23, 2015
    Applicant: GLYCOMIMETICS, INC.
    Inventors: John L. Magnani, Arun K. Sarkar, Myung-Gi Baek, Frank E. Anderson, III, Yanhong Li